PATENT CLAIM ANALYSIS

Application Number: 16066697
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "275000"]

Abstract:
Compounds represented by Formula I are disclosed herein, wherein R, Ra and R 1 -R 14  are as defined herein. Further disclosed are uses and methods utilizing said compounds for use in inhibiting an activity of PERK, and in treating a disease or disorder associated with aggregation-prone proteins, a disease or disorder in which downregulating an unfolded protein response is beneficial, and/or Huntington's disease.

Claim (Index 35):
The method of  claim 30 , wherein R is OR\u2032.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14849428', '15614278', '14436387', '13770676', '13770706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7266992764527194
- 35 USC 102 Novelty (BERT): 0.5221546144381061
- Combined Prediction Score: 0.7062448102512581
- Mean Citation Score: 251.687206
- Max Citation Score: 259.42258
- Similarity Product: 156.5538287868595

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test